Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$4.06
+1.12%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$11.00
Range $7.00 – $15.00
Implied Upside
+171.3%
Consensus $11.00 vs current $4.06
NASDAQ·Healthcare·Biotechnology
$4.06
+1.12%
Mkt Cap $14.65M
No recent rating data.
Price Target (3 analysts)
$11.00
Range $7.00 – $15.00
+171.3%
Consensus $11.00 vs current $4.06